Meet Christian Rommel
Christian Rommel became Roche’s Global Head of pRED Oncology in September 2018. Previously he was pRED’s Global Head of Oncology Discovery, a role held since 2014. He joined Roche from Amgen, where he was most recently Vice President of External Research and Development. Before that role, Christian was Amgen’s Vice President, Research Oncology.
Previously, Christian served as Chief Scientific Officer of Intellikine, a private biotech company based in San Diego, from its inception to acquisition by Takeda in December 2011. From 2000 to 2007, Christian was Head of Target Research at Merck Serono in Geneva, Switzerland. He also worked as a scientist in the team of George Yancopoulos at Regeneron Pharmaceuticals, New York.
Christian received his PhD in molecular oncology/signal transduction from the Max Planck Institute in Berlin, Germany and the Institute of Medical Virology at the University of Zurich, Switzerland. He has authored more than 70 publications, including papers in Science and Nature, and is an inventor or co-inventor of 18 patents.